Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2/3 1

Status

Completed 4Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 4

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 140Leukemia 132Lymphoma 90Leukemia, Myeloid, Acute 62Myelodysplastic Syndromes 47Burkitt Lymphoma 46Lymphoma, Non-Hodgkin 44Lymphoma, Large B-Cell, Diffuse 37Breast Neoplasms 37Lymphoma, Mantle-Cell 33Leukemia, Lymphocytic, Chronic, B-Cell 33Hodgkin Disease 32Multiple Myeloma 29Congenital Abnormalities 29Myeloproliferative Disorders 27Lymphoma, Follicular 27Leukemia, Myeloid, Accelerated Phase 27Graft vs Host Disease 27Leukemia, Myelomonocytic, Chronic 25Lymphoma, Large-Cell, Immunoblastic 24Leukemia, Myeloid, Chronic-Phase 24Blast Crisis 24Lymphoma, B-Cell, Marginal Zone 22Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20Anemia, Refractory, with Excess of Blasts 20Recurrence 18Primary Myelofibrosis 17Neoplasms, Plasma Cell 17Dendritic Cell Sarcoma, Interdigitating 17Osteosarcoma 16

Interventions

Cyclophosphamide 7blinatumomab 6Cytarabine 6fludarabine 5Mercaptopurine 5Methotrexate 4fludarabine phosphate 3Vincristine 3Rituximab 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Drug Therapy 3Dexamethasone 3Daunorubicin 3Asparaginase 3Whole-Body Irradiation 2Vindesine 2Thioguanine 2Teniposide 2Stem Cell Transplantation 2Prednisolone 2N,N-dicyclohexyl-isoborneol-10-sulfonamide 2Interleukin-2 2Doxorubicin 2Cladribine 2Blood Specimen Collection 2Azacitidine 2tisagenlecleucel 1thymoglobulin 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Neoplasm, Residual × Methotrexate × Clear all
NCT00198991 2022-08-18

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Goethe University

Phase 4 Completed
1,883 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00526175 2016-01-20

LAL-BR/2001: Study Treatment to Low Risk ALL

PETHEMA Foundation

Phase 4 Completed
150 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00795756 2014-10-22

Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia

Northern Italy Leukemia Group

Phase 2/3 Completed
145 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00199004 2010-08-23

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

Johann Wolfgang Goethe University Hospital

Phase 4 Completed
60 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡